Collaboration between giant pharmaceutical corporations and patients with very little power just doesn’t work, according to ...

The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

Many of those living with diabetes need insulin to survive, but the price of the medication in the United States is often expensive. That’s why the federal government and several drug companies ...

EAST LIVERPOOL, Ohio — For millions of Americans who rely on insulin to manage their diabetes, the price surge can pose ... injectables have seen an increase as of July 1.

The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...

The lawsuits generally make two claims: that insulin prices are unreasonably high and that drug companies and PBMs are responsible. The lawsuits are on firmer ground in their claim that PBMs are ...

The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices ... in anticompetitive practices that spur price ...

The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming unfair practices inflated the cost of insulin.

Insulin can be a critical part of managing diabetes, but patients may not know all the ins and outs of using the medication effectively. Luckily, the American Diabetes Association (ADA) has plenty ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.77% and ...